If you enjoy this show, please leave us a review wherever you listen and share Thoughts on the Market with a friend or a colleague today
Lu J, He L, Behrends C, Araki M, Araki K, Jun Wang Q, et al
Cai HY, Yang D, Qiao J, Yang JT, Wang ZJ, Wu MN, et al
J., Schoenfeld, B
Exenatide vs Liraglutide: First-Generation vs Second-Generation GLP-1 Agonists Evidence-based comparison of exenatide (Byetta/Bydureon) and liraglutide (Victoza/Saxenda), including the LEAD-6 head-to-head trial, DURATION vs SCALE data, and the evolution from exendin-4-based to human GLP-1-based analogs
Chronic conditions such as psoriasis and hidradenitis suppurativa are driven by systemic inflammatory pathways that overlap with obesity and insulin resistance